Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines

CONCLUSIONS: Taken together, these studies suggest that CCR1 expression may be associated with decreased response to bortezomib in MM cell lines.PMID:38479337 | DOI:10.1016/j.leukres.2024.107469
Source: Cell Research - Category: Cytology Authors: Source Type: research